{"id":"https://openalex.org/W4253476771","doi":"https://doi.org/10.1182/blood.v118.21.3564.3564","title":"Subnetwork-Based Analysis of Chronic Lymphocytic Leukemia Identifies Pathways That Associate with Disease Progression,","display_name":"Subnetwork-Based Analysis of Chronic Lymphocytic Leukemia Identifies Pathways That Associate with Disease Progression,","publication_year":2011,"publication_date":"2011-11-18","ids":{"openalex":"https://openalex.org/W4253476771","doi":"https://doi.org/10.1182/blood.v118.21.3564.3564"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v118.21.3564.3564","doi":"https://doi.org/10.1182/blood.v118.21.3564.3564","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v118.21.3564.3564","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067041449","display_name":"Han\u2010Yu Chuang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Han-Yu Chuang","raw_affiliation_strings":["Bioinformatics, UCSD, La Jolla, CA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioinformatics, UCSD, La Jolla, CA, USA,","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010336471","display_name":"Laura Z. Rassenti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura Z. Rassenti","raw_affiliation_strings":["Moores UCSD Cancer Center, University of California, San Diego, La Jolla, CA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moores UCSD Cancer Center, University of California, San Diego, La Jolla, CA, USA,","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047031080","display_name":"Michelle Salcedo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michelle Salcedo","raw_affiliation_strings":["Moores UCSD Cancer Center, University of California, San Diego, La Jolla, CA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moores UCSD Cancer Center, University of California, San Diego, La Jolla, CA, USA,","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000013079","display_name":"Kate S. Licon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kate Licon","raw_affiliation_strings":["Bioengineering, University of California, San Diego, La Jolla, CA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioengineering, University of California, San Diego, La Jolla, CA, USA,","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003682222","display_name":"Alexander Kohlmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093919","display_name":"Munich Leukemia Laboratory (Germany)","ror":"https://ror.org/00smdp487","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210093919"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Alexander Kohlmann","raw_affiliation_strings":["MLL Munich Leukemia Laboratory, Munich, Germany,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MLL Munich Leukemia Laboratory, Munich, Germany,","institution_ids":["https://openalex.org/I4210093919"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043414993","display_name":"Torsten Haferlach","orcid":"https://orcid.org/0000-0003-0196-2837","observed_orcids":["https://orcid.org/0000-0003-0196-2837"]},"institutions":[{"id":"https://openalex.org/I4210093919","display_name":"Munich Leukemia Laboratory (Germany)","ror":"https://ror.org/00smdp487","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210093919"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Torsten Haferlach","raw_affiliation_strings":["MLL Munich Leukemia Laboratory, Munich, Germany,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MLL Munich Leukemia Laboratory, Munich, Germany,","institution_ids":["https://openalex.org/I4210093919"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009431453","display_name":"Robin Fo\u00e0","orcid":"https://orcid.org/0000-0002-5021-3026","observed_orcids":["https://orcid.org/0000-0002-5021-3026"]},"institutions":[{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Robin Foa","raw_affiliation_strings":["Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy,","institution_ids":["https://openalex.org/I861853513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089373684","display_name":"Trey E. Ideker","orcid":"https://orcid.org/0000-0002-1708-8454","observed_orcids":["https://orcid.org/0000-0002-1708-8454"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Trey Ideker","raw_affiliation_strings":["Departments of Medicine and Bioengineering, University of California, San Diego, La Jolla, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicine and Bioengineering, University of California, San Diego, La Jolla, CA, USA","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036828560","display_name":"Thomas J. Kipps","orcid":"https://orcid.org/0000-0002-0064-4549","observed_orcids":["https://orcid.org/0000-0002-0064-4549"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Thomas Kipps","raw_affiliation_strings":["Moores UCSD Cancer Center, University of California, San Diego, La Jolla, CA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moores UCSD Cancer Center, University of California, San Diego, La Jolla, CA, USA,","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5000013079","https://openalex.org/A5036828560","https://openalex.org/A5067041449","https://openalex.org/A5089373684"],"corresponding_institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.4589,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.67445365,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"118","issue":"21","first_page":"3564","last_page":"3564"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":1.0},{"id":"https://openalex.org/keywords/disease-progression","display_name":"disease progression","score":0.871999979019165},{"id":"https://openalex.org/keywords/gene-expression-profiling","display_name":"gene expression profiling","score":0.7739999890327454},{"id":"https://openalex.org/keywords/gene-regulatory-networks","display_name":"gene regulatory networks","score":0.4090000092983246},{"id":"https://openalex.org/keywords/risk-stratification","display_name":"risk stratification","score":0.5830000042915344},{"id":"https://openalex.org/keywords/tumor-evolution","display_name":"tumor evolution","score":0.5400000214576721},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.39399999380111694},{"id":"https://openalex.org/keywords/survival-analysis","display_name":"survival analysis","score":0.4000000059604645},{"id":"https://openalex.org/keywords/cross-validation","display_name":"cross-validation","score":0.4650000035762787},{"id":"https://openalex.org/keywords/gene-expression-signatures","display_name":"gene expression signatures","score":0.32199999690055847},{"id":"https://openalex.org/keywords/temporal-gene-expression","display_name":"temporal gene expression","score":0.4440000057220459},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.5619999766349792},{"id":"https://openalex.org/keywords/treatment-free-survival","display_name":"treatment-free survival","score":0.3059999942779541},{"id":"https://openalex.org/keywords/relapse-free-survival","display_name":"relapse-free survival","score":0.5509999990463257},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.4519999921321869}],"concepts":[{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.6941605806350708},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.526416003704071},{"id":"https://openalex.org/C8415881","wikidata":"https://www.wikidata.org/wiki/Q6839217","display_name":"Microarray analysis techniques","level":4,"score":0.5241979956626892},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5238956212997437},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.48716995120048523},{"id":"https://openalex.org/C186836561","wikidata":"https://www.wikidata.org/wiki/Q1931516","display_name":"Microarray","level":4,"score":0.47180643677711487},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.47122323513031006},{"id":"https://openalex.org/C18431079","wikidata":"https://www.wikidata.org/wiki/Q1502169","display_name":"Gene expression profiling","level":4,"score":0.4363250732421875},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4350910186767578},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4202157258987427},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3858878016471863},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22089391946792603},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.2059849202632904},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.18681737780570984},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.10726621747016907}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v118.21.3564.3564","doi":"https://doi.org/10.1182/blood.v118.21.3564.3564","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v118.21.3564.3564","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8199999928474426,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2575873653","https://openalex.org/W7095209703","https://openalex.org/W2176253251","https://openalex.org/W4292018632","https://openalex.org/W2170617812","https://openalex.org/W2153794402","https://openalex.org/W2588677323","https://openalex.org/W1971128326","https://openalex.org/W2024629612","https://openalex.org/W2560384002"],"abstract_inverted_index":{"Abstract":[0,1],"3564":[2],"The":[3,95,163,196,428,532],"clinical":[4,96],"course":[5],"of":[6,79,87,98,130,136,158,166,176,186,209,221,246,257,268,326,346,355,358,437,459,462,541],"patients":[7,17,46,88,177,188,261,275,286,351,373,415,477,519],"with":[8,89,276,285,308,329,352],"chronic":[9],"lymphocytic":[10],"leukemia":[11],"(CLL)":[12],"is":[13],"heterogeneous.":[14],"Whereas":[15],"some":[16,258],"develop":[18],"aggressive":[19,290],"disease":[20,29,56,93,151,279,291,309,330],"requiring":[21,153,204],"early":[22],"treatment,":[23],"others":[24],"can":[25,44],"have":[26,40,62,289,336],"highly":[27],"indolent":[28,278],"and":[30,102,128,182,223,342,388,450,492,554],"not":[31],"require":[32],"therapy":[33,154,205],"for":[34,55,92,122,150,203,338,343,350,382,411,418,486,515,522],"many":[35],"years.":[36],"Several":[37],"prognostic":[38,142,164],"factors":[39],"been":[41],"identified":[42,140,197,321],"that":[43,49,144,297,305],"stratify":[45,363,467],"into":[47,302],"groups":[48,86,393,431,497,535],"differ":[50],"in":[51,65,115,125,178,228,235,253,274,314,422,526],"their":[52],"relative":[53,148],"tendency":[54],"progression":[57,152],"and/or":[58],"survival.":[59],"Microarray":[60,113],"studies":[61,230],"highlighted":[63],"differences":[64],"mRNA":[66],"levels":[67,256,267,357,461],"found":[68,287],"between":[69,85,260],"such":[70,269],"CLL":[71,187],"subgroups.":[72],"Here,":[73],"we":[74,139],"pursued":[75],"a":[76,173],"subnetwork-based":[77],"analysis":[78],"gene":[80,236,402,506],"expression":[81,237,255,266,356,460],"profiles":[82],"to":[83,281,288,316,362,466],"discriminate":[84],"disparate":[90],"risks":[91],"progression.":[94,310,331],"characterization":[97],"patients,":[99,138],"blood-sample":[100],"preparation,":[101],"microarray":[103,225],"processing":[104],"all":[105],"follow":[106],"the":[107,112,126,147,156,179,191,201,207,224,232,254,265,344,371,384,412,419,441,445,451,475,488,516,523,545,549,555],"unified":[108],"protocol":[109],"implemented":[110],"by":[111,395,401,434,499,505,538],"Innovations":[114],"LEukemia":[116],"(MILE)":[117],"program,":[118],"which":[119],"proposed":[120],"standards":[121],"microarray-based":[123],"assays":[124],"diagnosis":[127],"sub-classification":[129],"leukemia.":[131],"From":[132],"an":[133,324],"initial":[134],"cohort":[135,175,421,525],"130":[137,372,476],"38":[141,446,550],"subnetworks":[143,168,198,259,271,322,361,447,465,551],"could":[145,199,272],"predict":[146],"risk":[149,202,392,430,496,534],"from":[155,374,478],"time":[157,208],"sample":[159],"collection":[160,211],"(Fig.":[161,194,217],"1A).":[162],"power":[165],"these":[167,222,320,334],"then":[169],"was":[170,238,250],"validated":[171],"on":[172,183,370,378,409,440,474,482,513,544],"second":[174],"MILE":[180,192],"study":[181],"another":[184],"set":[185],"evaluated":[189],"outside":[190],"program":[193],"1B).":[195],"assess":[200],"at":[206,292],"tissue":[210],"more":[212],"accurately":[213],"than":[214],"established":[215],"markers":[216,438,542],"1C).":[218],"Statistical":[219],"analyses":[220,295,377,481],"data":[226],"collected":[227,242],"prior":[229],"revealed":[231],"greatest":[233],"divergence":[234],"observed":[239],"using":[240],"samples":[241],"within":[243],"1":[244],"year":[245],"diagnosis.":[247,293],"Thereafter":[248],"there":[249],"increasing":[251],"congruence":[252],"over":[262],"time.":[263],"Moreover,":[264],"predictive":[270,318],"evolve":[273],"otherwise":[277],"characteristics":[280],"resemble":[282],"those":[283],"associated":[284,307,328],"These":[294],"suggest":[296],"degenerate":[298],"pathways":[299,304,327],"apparently":[300],"converge":[301],"common":[303],"are":[306,380,432,484,536],"We":[311],"conclude":[312],"that,":[313],"addition":[315],"having":[317],"power,":[319],"represent":[323],"array":[325],"As":[332],"such,":[333],"results":[335],"implications":[337],"understanding":[339],"cancer":[340],"evolution":[341],"development":[345],"novel":[347],"treatment":[348],"strategies":[349],"CLL.Figure":[353],"1Use":[354],"genes":[359,454,463,558],"versus":[360,464],"patient":[364,420,468,524],"samples.":[365,469],"(A)":[366,470],"Five-fold":[367,471],"cross":[368,472],"validation":[369,473],"UCSD.":[375,479],"Survival":[376,407,480,511],"SC\u2192TX":[379,410,483,514],"shown":[381,485],"both":[383,487],"low":[385,489],"(dashed":[386,490],"lines)":[387,391,399,449,491,495,503,553],"high":[389,493],"(solid":[390,494],"predicted":[394,433,498,537],"subnetwork":[396,500],"signatures":[397,403,501,507],"(red":[398,448,502,552],"or":[400,417,504,521],"(green":[404,455,508,559],"lines).":[405,509,560],"(B-C)":[406,510],"curves":[408,512],"17":[413,517],"European":[414,518],"(B)":[416,520],"Friedman":[423,527],"et":[424,528],"al":[425,529],"(2009)":[426,530],"(C).":[427,531],"two":[429,435,533,539],"sets":[436,540],"developed":[439,543],"UCSD":[442,546],"cohort,":[443,547],"including":[444,548],"top":[452,556],"230":[453,557],"lines).Figure":[456],"1.":[457],"Use":[458],"Disclosures:":[561],"Foa:":[562],"Roche:":[563],"Consultancy,":[564],"Speakers":[565],"Bureau.":[566]},"counts_by_year":[{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-05-12T00:00:00"}